A vaccination programme introduced to protect babies and older adults against a dangerous respiratory disease has cut ...

Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...

The respiratory syncytial virus (RSV) vaccine triggered strong immune responses among people aged 60 years and older during ...

A vaccination program has cut hospital admissions for a respiratory virus among older people in Scotland by nearly two-thirds ...

A study today in JAMA Network Open from the University of California, San Francisco (UCSF), shows a high uptake of respiratory syncytial virus (RSV) vaccine and the RSV-preventing monoclonal antibody ...

High uptake of RSVpreF vaccine and nirsevimab was observed, with 64% of pregnant individuals and 70% of infants receiving ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.

MORE than one million people in England are being urged to get a life-saving new vaccine. It protects against respiratory ...

Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a ...

Those most at risk from RSV include babies under 6 months old, young children who were born prematurely, and adults over ...

Kids who are not up to date on vaccinations will be excluded from school or daycare unless they have an exemption.